What is aTyr Pharma's investment proceeds?

aTyr Pharma (ATYR) reported investment proceeds of $17.5M in Q1 2026.

How has aTyr Pharma's investment proceeds changed year-over-year?

aTyr Pharma's investment proceeds decreased by 6.3% year-over-year, from $18.69M to $17.5M.

What is the long-term trend for aTyr Pharma's investment proceeds?

Over 4 years (2021 to 2025), aTyr Pharma's investment proceeds has grown at a 26.0% compound annual growth rate (CAGR), from $35.08M to $88.46M.

What does investment proceeds mean?

Cash received from sales, maturities, and redemptions of investment securities across all categories.

aTyr Pharma ATYR Investment Proceeds

Investment Proceeds at other companies

United TherapeuticsUTHR

$1.31B—

Design Therapeutics, Inc.DSGN

$45M-52.4%

CytomX TherapeuticsCTMX

$50M-1.0%

Rigel PharmaceuticalsRIGL

$15.95M+43.6%

Syndax PharmaceuticalsSNDX

$77.78M-25.7%

Gyre Therapeutics, Inc.GYRE

$10.07M-10.0%

Other financials

Income statement

See full

Revenue-—

Operating income-$11.4M+27.5%

Net income-$10.8M+27.5%

EPS (diluted)-$0.11+35.3%

Balance sheet

See full

Cash & equivalents$10.0M-3.4%

Total debt$12.3M-9.2%

Total equity$57.9M-22.8%

Total assets$79.7M-18.1%

Cash flow

See full

Operating cash flow-$12.5M+18.8%

CapEx$138.0K—

Free cash flow-$12.7M+17.9%

Valuation

See full

Market cap$54.88M-88.2%

Enterprise value$57.17M—

P/S288.8×—

Profitability

See full

Operating margin-40,856.3%+28,833pp

Net margin-39,009.5%+29,653pp

FCF margin-32,664.7%+4,018pp

Returns & leverage

See full

Return on equity-105.3%+50.6pp

Debt / equity0.2×0.0×

Current ratio5.8×-2.0×

Where this comes from

Reported directly by aTyr Pharma in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities.

The official record: aTyr Pharma’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about aTyr Pharma's investment proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is aTyr Pharma's investment proceeds?: aTyr Pharma (ATYR) reported investment proceeds of $17.5M in Q1 2026.
How has aTyr Pharma's investment proceeds changed year-over-year?: aTyr Pharma's investment proceeds decreased by 6.3% year-over-year, from $18.69M to $17.5M.
What is the long-term trend for aTyr Pharma's investment proceeds?: Over 4 years (2021 to 2025), aTyr Pharma's investment proceeds has grown at a 26.0% compound annual growth rate (CAGR), from $35.08M to $88.46M.
What does investment proceeds mean?: Cash received from sales, maturities, and redemptions of investment securities across all categories.